Neil Gregory Almstead serves as Executive at PTC THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Neil Gregory Almstead has executed 157 insider transactions totaling $29.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 20, 2015 involved selling 24,600 shares valued at $1.5M.
Neil Gregory Almstead currently holds 102,189 shares of PTC THERAPEUTICS, INC. (PTCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neil Gregory Almstead has been a net seller of PTCT stock. They have purchased $0 and sold $29.0M worth of shares.
Neil Gregory Almstead's most recent insider trade was on Jan 20, 2015, when they sold 24,600 shares at $60.25 per share.
Get notified when new Form 4 filings are submitted
| $10.85 |
| Discretionary |
| Jan 20, 2015 | PTCT | $30.5K | Sale | 500 | $61.02 | Discretionary |
| Jan 20, 2015 | PTCT | $218.1K | Option Exercise | 20,100 | $10.85 | Discretionary |
| Dec 4, 2014 | PTCT | $8.8K | Sale | 175 | $50.00 | Discretionary |
| Mar 19, 2014 | PTCT | $16.1K | Sale | 500 | $32.21 | Discretionary |
| Mar 19, 2014 | PTCT | $330.5K | Sale | 10,359 | $31.90 | Discretionary |